- NCT00036556
Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
Phase 3Completed - NCT00036569
A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas
Phase 2Completed - NCT00036491
Anti-CD20 in Systemic Lupus Erythematosus
Phase 1Completed - NCT00036439
A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis
Phase 3Completed - NCT00036426
Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma
Phase 2Unknown - NCT00036335
Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain
Phase 3Completed - NCT00036361
Broad Effectiveness: Study With Aripiprazole
Phase 3Completed - NCT00036387
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis.
Phase 3Completed - NCT00036348
Study of Aripiprazole in Patients With a History of Bipolar Disorder
Phase 3Completed - NCT00036413
A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis
Phase 2Completed - NCT00036400
Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy, Followed by Surgery
Phase 3Completed - NCT00036374
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis
Phase 3Completed - NCT00036153
Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis
Phase 3Completed - NCT00036140
Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma
Phase 1Completed - NCT00036244
Synthetic Human Secretin in Children With Autism
Phase 3Completed - NCT00036257
Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia
Phase 1Completed - NCT00036218
Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.
Phase 3Completed - NCT00036283
Chemoprevention of Oral Premalignant Lesions
Phase 2Completed - NCT00036231
Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction
Phase 3Terminated - NCT00036309
Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder
Phase 3Completed - NCT00036270
Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane
Phase 3Completed - NCT00036101
Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder
Phase 3Completed - NCT00036296
Effects of Talampanel on Patients With Advanced Parkinson's Disease
Phase 1Completed - NCT00036114
Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
Phase 3Completed - NCT00036127
Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders
Phase 2Completed - NCT00036166
Study of FK463 for the Treatment of Invasive Aspergillosis
Phase 2Completed - NCT00036179
Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis
Phase 2Completed - NCT00036192
Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea
Phase 2Completed - NCT00036205
Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease
Phase 3Terminated - NCT00035997
Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis
Phase 4Completed - NCT00035958
Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis
Phase 2Terminated - NCT00036023
Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies
Phase 2Completed - NCT00036075
Study Using CP-461 to Treat Advanced Prostate Cancer
Phase 2Completed - NCT00036062
A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury
Phase 1Completed - NCT00035971
EVA: Evista Alendronate Comparison
Phase 4Completed - NCT00035932
Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV
Phase 3Completed - NCT00035945
ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus Infections
Phase 2Completed - NCT00036036
Study of CP-461 in Patients With Advanced Renal Cell Cancer
Phase 2Completed - NCT00036088
Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
Phase 4Completed - NCT00035984
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
Phase 3Completed - NCT00035815
Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) Trial
Phase 3Completed - NCT00035802
A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder
Phase 3Completed - NCT00035906
Research Study in Patients With Persistent Macular Edema
Phase 2Completed - NCT00035893
The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART
Phase 2Completed - NCT00035880
Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease
Phase 2Completed - NCT00035867
Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
Phase 1Completed - NCT00035854
New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)
Phase 3Completed - NCT00035841
Phase 2 Study of TLK286 in Metastatic Breast Cancer
Phase 2Completed - NCT00035828
A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD
Phase 2Completed - NCT00035919
Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to Liver
Phase 1Withdrawn - NCT00035503
Multicenter Trial For Patients With Acute Crohn's Disease
Phase 2Completed - NCT00035347
Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia
Phase 4Completed - NCT00035360
Phase III PEG-Intron in HIV-infected Patients (Study P00738)
Phase 3Completed - NCT00035412
St. John's Wort Versus Placebo in Social Phobia
Phase 2Completed - NCT00035425
Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection
Phase 3Completed - NCT00035438
St. John's Wort Vs. Placebo in Obsessive-Compulsive Disorder.
Phase 2Completed - NCT00035516
A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy
Phase 2Completed - NCT00035542
A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.
Phase 3Completed - NCT00035568
A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes
Phase 4Completed - NCT00035581
Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART
Phase 2Terminated - NCT00035607
Chemotherapy Related Anemia
Phase 2Completed - NCT00035633
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen
Phase 3Completed - NCT00035659
Longitudinal Study of the Menopause and Fat Patterning
Completed - NCT00035672
Genetic Predictors of Incident Cardiovascular Disease
Withdrawn - NCT00035685
Exposure of Children With Asthma to Household Environmental Tobacco Smoke
Completed - NCT00035698
Epidemiological and Genetic Studies of Body Mass Index
Completed - NCT00035711
VA HDL Intervention Trial (VA-HIT) Ancillary Study Data Analysis
Completed - NCT00035724
Monitoring Community Trends in Heart Failure
Completed - NCT00035737
Vascular Function in the Framingham Third Generation
Completed - NCT00035750
Risk Factors for Atherogenesis in Type 1 Diabetes
Completed - NCT00035763
Pain in Sickle Cell Epidemiologic Study
Completed - NCT00035776
Blood Factors and Peripheral Arterial Disease Outcomes
Completed - NCT00035789
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen
Phase 3Completed - NCT00035464
Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation.
Phase 3Completed - NCT00035620
Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy
Phase 2Completed - NCT00035555
Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney
Phase 2Completed - NCT00035451
Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation.
Phase 3Completed - NCT00035477
Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation
Phase 3Completed - NCT00035529
A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis
Phase 2Terminated - NCT00035490
Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators
Phase 3Completed - NCT00035594
Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy
Phase 3Completed - NCT00035399
Efficacy of Acupuncture With Physical Therapy for Knee Osteo-Arthritis
Phase 3Completed - NCT00035321
The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression
Phase 3Completed - NCT00034788
A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX
Phase 3Terminated - NCT00034801
Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia
Phase 4Completed - NCT00035386
Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Study
Phase 2Completed - NCT00034827
A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer
Phase 2Completed - NCT00034840
Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose
Phase 4Completed - NCT00034853
Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)
Phase 3Completed - NCT00035373
Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols
Terminated - NCT00035165
EPO906 Therapy in Patients With Advanced Melanoma
Phase 2Completed - NCT00035178
Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemodialysis
Phase 4Completed - NCT00034775
A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.
Phase 3Completed - NCT00035191
A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia
Phase 3Completed - NCT00034762
Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease
Phase 3Completed - NCT00035100
EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer
Phase 2Completed - NCT00034749
The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia
Phase 3Completed - NCT00035113
EPO906 Therapy in Patients With Prostate Cancer
Phase 2Completed - NCT00034736
A Study to Compare the Efficacy and Safety of Levofloxacin in the Treatment of Children With Community-acquired Pneumonia in the Hospital or Outpatient Setting
Phase 3Completed - NCT00034879
Iressa Expanded Access Program (EAP)
Phase 3Completed